|
1
|
Sliva D, Jedinak A, Kawasaki J, Harvey K
and Slivova V: Phellinus linteus suppresses growth, angiogenesis
and invasive behaviour of breast cancer cells through the
inhibition of AKT signalling. Br J Cancer. 98:1348–1356. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Y, Wan Y, Wang Y, Zhang H and Jiao Z:
Anticancer efficacy enhancement and attenuation of side effects of
doxorubicin with titanium dioxide nanoparticles. Int J
Nanomedicine. 6:2321–2326. 2011.PubMed/NCBI
|
|
3
|
Sun Y, Sun T, Wang F, Zhang J, Li C, Chen
X, Li Q and Sun S: A polysaccharide from the fungi of Huaier
exhibits anti-tumor potential and immunomodulatory effects.
Carbohydr Polym. 92:577–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yi Y, Zhang MW, Liao ST, Zhang RF, Deng
YY, Wei ZC, Tang XJ and Zhang Y: Structural features and
immunomodulatory activities of polysaccharides of longan pulp.
Carbohydr Polym. 87:636–643. 2012. View Article : Google Scholar
|
|
5
|
Fabricant DS and Farnsworth NR: The value
of plants used in traditional medicine for drug discovery. Environ
Health Perspect 109 Suppl. 1:S69–S75. 2001. View Article : Google Scholar
|
|
6
|
Gao C, Zhong L, Jiang L, Geng C, Yao X and
Cao J: Phellinus linteus mushroom protects against tacrine-induced
mitochondrial impairment and oxidative stress in HepG2 cells.
Phytomedicine. 20:705–709. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao R, Gao X, Cai Y, Shao X, Jia G, Huang
Y, Qin X, Wang J and Zheng X: Antitumor activity of Portulaca
oleracea L. polysaccharides against cervical carcinoma in vitro and
in vivo. Carbohydr Polym. 96:376–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zou X, Sun M and Guo X: Quantitative
response of cell growth and polysaccharide biosynthesis by the
medicinal mushroom Phellinus linteus to NaCl in the medium. World J
Microb Biot. 22:1129–1133. 2006. View Article : Google Scholar
|
|
9
|
Li X, Jiao LL, Zhang X, Tian WM, Chen S
and Zhang LP: Anti-tumor and immunomodulating activities of
proteoglycans from mycelium of Phellinus nigricans and culture
medium. Int Immunopharmacol. 8:909–915. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He P, Geng L, Wang J, Wang Z, Mao D and Xu
C: Purification, characterization and bioactivity of an
extracellular polysaccharide produced from Phellinus igniarius. Ann
Microbiol. 62:1697–1707. 2012. View Article : Google Scholar
|
|
11
|
Li YG, Ji DF, Zhong S, Liu PG, Lv ZQ, Zhu
JX, Chen JE and Chen HP: Polysaccharide from Phellinus linteus
induces S-phase arrest in HepG2 cells by decreasing calreticulin
expression and activating the P27kip1-cyclin A/D1/E-CDK2 pathway. J
Ethnopharmacol. 150:187–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhong S, Ji DF, Li YG, Lin TB, Lv ZQ and
Chen HP: Activation of P27kip1-cyclin D1/E-CDK2 pathway by
polysaccharide from Phellinus linteus leads to S-phase arrest in
HT-29 cells. Chem Biol Interact. 206:222–229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zong A, Cao H and Wang F: Anticancer
polysaccharides from natural resources: A review of recent
research. Carbohydr Polym. 90:1395–1410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu SJ, Liaw CC, Pan SZ, Yang HC and Ng LT:
Phellinus linteus polysaccharides and their immunomodulatory
properties in human monocytic cells. J Funct Foods. 5:679–683.
2013. View Article : Google Scholar
|
|
15
|
Blattman JN and Greenberg PD: Cancer
immunotherapy: A treatment for the masses. Science. 305:200–205.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gajewski TF, Woo SR, Zha Y, Spaapen R,
Zheng Y, Corrales L and Spranger S: Cancer immunotherapy strategies
based on overcoming barriers within the tumor microenvironment.
Curr Opin Immunol. 25:268–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Landskron G, De la Fuente M, Thuwajit P,
Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in
the tumor microenvironment. J Immunol Res. 2014:1491852014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Xiong S, Li A, Huang N, Lu F and Hou D:
Antioxidant and immunoregulatory activity of different
polysaccharide fractions from tuber of Ophiopogon japonicus.
Carbohydr Polym. 86:1273–1280. 2011. View Article : Google Scholar
|
|
19
|
Jeff IB, Yuan X, Sun L, Kassim RM, Foday
AD and Zhou Y: Purification and in vitro anti-proliferative effect
of novel neutral polysaccharides from Lentinus edodes. Int J Biol
Macromol. 52:99–106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mou ZZ, Wang MF, Gao WW, Zhang N and Yu
SW: Extraction of Phellinus igniarius polysaccharides and
composition analysis of monosaccharide. Chin J Experimental
Traditional Medical Formulae. 20:13–15. 2014.(In Chinese).
|
|
21
|
Chen L, Pan J, Li X, Zhou Y, Meng Q and
Wang Q: Endo-polysaccharide of Phellinus igniarius exhibited
anti-tumor effect through enhancement of cell mediated immunity.
Int Immunopharmacol. 11:255–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang HY, Chieh SY, Tso TK, Chien TY, Lin
HT and Tsai YC: Orally administered mycelial culture of Phellinus
linteus exhibits antitumor effects in hepatoma cell-bearing mice. J
Ethnopharmacol. 133:460–466. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
De Silva DD, Rapior S, Fons F, Bahkali AH
and Hyde KD: Medicinal mushrooms in supportive cancer therapies: An
approach to anti-cancer effects and putative mechanisms of action.
Fungal Diversity. 55:1–35. 2012. View Article : Google Scholar
|
|
24
|
Wong KH, Lai CK and Cheung PC:
Immunomodulatory activities of mushroom sclerotial polysaccharides.
Food Hydrocolloids. 25:150–158. 2011. View Article : Google Scholar
|
|
25
|
Xie G, Schepetkin IA and Quinn MT:
Immunomodulatory activity of acidic polysaccharides isolated from
Tanacetum vulgare L. Int Immunopharmacol. 7:1639–1650. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cella M, Scheidegger D, Palmer-Lehmann K,
Lane P, Lanzavecchia A and Alber G: Ligation of CD40 on dendritic
cells triggers production of high levels of interleukin-12 and
enhances T cell stimulatory capacity: T-T help via APC activation.
J Exp Med. 184:747–752. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qin Z and Blankenstein T: CD4+ T
cell-mediated tumor rejection involves inhibition of angiogenesis
that is dependent on IFN gamma receptor expression by
nonhematopoietic cells. Immunity. 12:677–686. 2000. View Article : Google Scholar : PubMed/NCBI
|
